CORC

在结果中检索

CORC

浏览/检索结果: 共92条，第1-10条 帮助

限定条件    
已选(0)清除 条数/页：   排序方式：
Comparison of Concurrent Cisplatin Chemoradiotherapy Plus Adjuvant Chemotherapy Versus Concurrent Chemoradiotherapy Alone in Locally Advanced Cervical Cancer 会议论文
61st Annual Meeting of the American-Society-for-Radiation-Oncology (ASTRO), SEP 15-18, 2019
作者:  Chen, S.;  Ren, T.;  Wang, X.;  Shen, Y.;  Ning, X.
收藏  |  浏览/下载：5/0  |  提交时间：2019/12/31
CTONG 1103: Erlotinib versus gemcitabine plus cisplatin as neo-adjuvant treatment for stage IIIA-N2 EGFR-mutation non- small cell lung cancer (EMERGING): A randomised study 会议论文
作者:  Zhong, W-Z.;  Wu, Y-L.;  Chen, K-N.;  Chen, C.;  Gu, C-D.
收藏  |  浏览/下载：2/0  |  提交时间：2019/12/05
First-line cetuximab plus cisplatin and fluorouracil vs cisplatin and fluorouracil in Chinese patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck: The randomized, phase III CHANGE-2 trial 会议论文
作者:  Guo, Y.;  Luo, Y.;  Zhang, Q.;  Huang, X.;  Li, Z.
收藏  |  浏览/下载：10/0  |  提交时间：2019/12/05
A phase II randomized trial of gemcitabine plus cisplatin(GP) vs. gemcitabine plus carboplatin (GC) as the first-line treatment for patients with metastatic triple negative breast cancer 会议论文
作者:  Gong, Chengcheng;  Cao, Enying;  Wang, Zhonghua;  Zhang, Jian;  Wang, Leiping
收藏  |  浏览/下载：6/0  |  提交时间：2019/12/05
Final results of a phase 3 study of comparing paclitaxel plus 5-fluorouracil versus cisplatin plus 5-fluorouracil in chemoradiotherapy for locally advanced esophageal carcinoma (ESO-Shanghai 1). 会议论文
作者:  Chen, Yun;  Ye, Jingjun;  Zhu, Zhengfei;  Zhao, Weixin;  Li, Ling
收藏  |  浏览/下载：11/0  |  提交时间：2019/12/05
Final Results of a Phase 3 Study of Comparing Paclitaxel Plus 5-Fluorouracil versus Cisplatin Plus 5-Fluorouracil in Chemoradiotherapy for Locally Advanced Esophageal Carcinoma 会议论文
作者:  Chen, Y.;  Ye, J.;  Zhu, Z.;  Zhao, W.;  Li, L.
收藏  |  浏览/下载：9/0  |  提交时间：2019/12/05
CTONG 1103: Erlotinib versus gemcitabine plus cisplatin as neo-adjuvant treatment for stage IIIA-N2 EGFR-mutation non- small cell lung cancer (EMERGING): A randomised study 会议论文
作者:  Zhong, W-Z.;  Wu, Y-L.;  Chen, K-N.;  Chen, C.;  Gu, C-D.
收藏  |  浏览/下载：9/0  |  提交时间：2019/11/19
First-line cetuximab plus cisplatin and fluorouracil vs cisplatin and fluorouracil in Chinese patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck: The randomized, phase III CHANGE-2 trial 会议论文
ANNALS OF ONCOLOGY, 2018-11-01
作者:  Guo, Y.;  Luo, Y.;  Zhang, Q.;  Huang, X.;  Li, Z.
收藏  |  浏览/下载：4/0  |  提交时间：2020/01/03
A multicenter, randomized, open-label, phase II trial of erlotinib versus etoposide plus cisplatin with concurrent radiotherapy in unresectable stage III non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) activating mutation. 会议论文
作者:  Xing, Ligang;  Wu, Gang;  Wang, Lvhua;  Li, Jian-Cheng;  Wang, Jianhua
收藏  |  浏览/下载：3/0  |  提交时间：2019/12/05
Efficacy and Safety of Erlotinib vs Vinorelbine/Cisplatin as Adjuvant Therapy for Stage IIIA EGFR Mutant NSCLC Patients 会议论文
作者:  Yue, D.;  Xu, S.;  Wang, Q.;  Li, X.;  Shen, Y.
收藏  |  浏览/下载：4/0  |  提交时间：2019/12/05

©版权所有 ©2017 CSpace - Powered by CSpace